12:00 AM
 | 
Jul 28, 2003
 |  BioCentury  |  Emerging Company Profile

Corporate Profile

igeneon AG

Vienna, Austria

Technology: Cancer immunotherapies

Disease focus: Epithelial cancer

Clinical status: Phase II/III

Founded: 1999 by Hans...

Read the full 71 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >